These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD. Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500 [TBL] [Abstract][Full Text] [Related]
3. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Rog DJ; Nurmikko TJ; Young CA Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205 [TBL] [Abstract][Full Text] [Related]
4. Medicinal cannabis extracts for the treatment of multiple sclerosis. Smith PF Curr Opin Investig Drugs; 2004 Jul; 5(7):727-30. PubMed ID: 15298068 [TBL] [Abstract][Full Text] [Related]
5. Sativex for the management of multiple sclerosis symptoms. Perras C Issues Emerg Health Technol; 2005 Sep; (72):1-4. PubMed ID: 16317825 [TBL] [Abstract][Full Text] [Related]
6. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Russo EB; Guy GW; Robson PJ Chem Biodivers; 2007 Aug; 4(8):1729-43. PubMed ID: 17712817 [TBL] [Abstract][Full Text] [Related]
8. Cannabis derivatives and pain. A small role for delta9-tetrahydrocannabinol (THC) in some forms of multiple sclerosis. Prescrire Int; 2009 Oct; 18(103):226. PubMed ID: 19882800 [No Abstract] [Full Text] [Related]
9. From exotic spice to modern drug? Singh S Cell; 2007 Sep; 130(5):765-8. PubMed ID: 17803897 [TBL] [Abstract][Full Text] [Related]
10. Dexlansoprazole, a modified release formulation of an enantiomer of lansoprazole, for the treatment of reflux esophagitis. Fock KM; Ang TL Curr Opin Investig Drugs; 2008 Oct; 9(10):1108-15. PubMed ID: 18821474 [TBL] [Abstract][Full Text] [Related]
11. Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection. Parish D; Scheinfeld N Curr Opin Investig Drugs; 2008 Feb; 9(2):201-9. PubMed ID: 18246523 [TBL] [Abstract][Full Text] [Related]
12. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer. Tamm I Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763 [TBL] [Abstract][Full Text] [Related]
13. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law. Dinh TQ Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027 [No Abstract] [Full Text] [Related]
17. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection. Fletcher PS; Shattock RJ Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522 [TBL] [Abstract][Full Text] [Related]
18. Drug evaluation: zanolimumab, a human monoclonal antibody targeted against CD4. Assaf C; Sterry W Curr Opin Mol Ther; 2007 Apr; 9(2):197-203. PubMed ID: 17458175 [TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. GarcĂa-Merino A Expert Rev Neurother; 2013 Feb; 13(3 Suppl 1):9-13. PubMed ID: 23369054 [TBL] [Abstract][Full Text] [Related]
20. Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections. Peppard WJ; Schuenke CD Curr Opin Investig Drugs; 2008 Feb; 9(2):210-25. PubMed ID: 18246524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]